SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (126)11/21/1996 10:15:00 PM
From: Brad C. Dunlap   of 1762
 
Hi Bennett, I just had printed F.S. Wang's post, logged off, and realized that he didn't mention the number of patients. Assuming that there were no additional patients and todays info is just an update on the past results with the number of complete responses going from 66%[19 out of 29 released in March] to 60% would imply excellent results in duration of reponse. Back in March the ongoing duration of response was 6-22 months. With an additional 8 months added since the March release we could see some complete response durations up to 30 months. I'm just speculating but seems very exciting.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext